Global Chronic Gingivostomatitis Treatment Market
Overview:
Chronic gingivostomatitis is a common mouth and gum infection (common among children) which leads to swelling and drooling. Gingivostomatitis is generally spread through the saliva of an infected person. The symptoms of gingivostomatitis are blisters on the cheeks, gums, tongue, lips, roof of the mouth, fever, bad breath, red swollen gums, pain around gums and mouth, and reluctant to eat and drink. Gingivostomatitis may be subclinical in some cases, which means the signs are not severe or easy to recognise and diagnose.
Request for Analysis of COVID-19 Impact on Chronic Gingivostomatitis Treatment Market – https://www.coherentmarketinsights.com/insight/request-sample/4308
Drivers:
Increasing focus towards product development by key players for chronic gingivostomatitis treatment is expected to augment growth of the global chronic gingivostomatitis treatment market during the forecast period. For instance, in April 2020, GlaxoSmithKline offered Zovirax, a cream with active ingredient, aciclovir, for antiviral treatment for cold sores.
Rising prevalence of gingivostomatitis is expected to boost growth of the global chronic gingivostomatitis treatment market. For instance, according to the report published in Journal of Dental Health, Oral Disorders & Therapy, in 2017, primary herpetic gingivostomatitis (PHG) is a common pediatric infection usually seen before 6 years of age, which is mostly i.e. 90% caused by Herpes Simplex Virus (HSV) type.
COVID-19 Impact:
The emergence of COVID-19 has affected financial status of several industry verticals worldwide. The private healthcare sector is one of the sectors, which has been majorly impacted by the global pandemic. Moreover, the pandemic has affected growth of various companies due to safety measures implemented by many governments worldwide. The pandemic has affected the economy in three major ways, such as by creating disruptions in distribution channels, by directly affecting production and demand, and through its financial impact on healthcare markets across the globe.
As a result, the pandemic is expected to hamper the global chronic gingivostomatitis treatment market growth over the forecast period.
Reasons to Purchase this Report
• Current and future of global Chronic Gingivostomatitis Treatment market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Buy Now this Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/4308
Segmentation:
By Drug Type:
- Microbial Culture Biopsy
- Physical Examination
By Treatment:
- Antiviral
- Antibacterial
- Non-steroidal Anti-inflammatory Drugs
By End User:
- Hospitals & Clinics
- Academic & Research
By Region:
- North America
- Europe
- Asia Pacific
- Middle east
- Latin America
- Africa
View Press Release For More Information
Regional Analysis:
North America is expected to witness robust growth in the global chronic gingivostomatitis treatment market due to increasing incidence of chronic gingivostomatitis in the region. For instance, according to a report published in the Western Journal of Emergency Medicine, an article, in 2018, there were around 115,726 number of patient visits with primary diagnosis during 2006 to 2013 in the United States.
Competitive Section:
Key players active in the global chronic gingivostomatitis treatment market are Novartis AG, Taj Pharmaceutical limited, Pfizer Inc., GlaxoSmithKline PLC, Merck & CO., Inc., F. Hoffman La Roche AG, Eli Lily, Ciron pharma, Johnson & Johnson, and Company, and AstraZeneca Plc.
In December 2020, Heritage Pharms offered ZOVIRAX (acyclovir), a suspension, a generic version of the GlaxoSmithKlines’ Zovirax.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Diagnosis
- Market Snippet, By Treatment
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- Reimbursement Scenario
- Epidemiology
- Pest Analysis
- Regulatory Scenario
- New Product Launches
- Collaborations and Agreements
- Market Trends
- Market Dynamics
- Global Chronic Gingivostomatitis Treatment Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Market Scenario
- Impact of COVID-19 Market on the Chronic Gingivostomatitis Treatment Products
- Global Chronic Gingivostomatitis Treatment Market, By Diagnosis, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Physical Examination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Microbial Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Chronic Gingivostomatitis Treatment Market, By Treatment, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Non-steroidal Anti-inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Antiviral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Antibacterial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Chronic Gingivostomatitis Treatment Market, By End User, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Academic & Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Chronic Gingivostomatitis Treatment Market, By Region, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2027
- North America
- Market Size and Forecast, By Diagnosis, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- S.
- Canada
- Latin America
- Market Size and Forecast, By Diagnosis, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Diagnosis, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Diagnosis, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Diagnosis, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Diagnosis, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837